REGISTERED NUMBER: 06434893 (England and Wales)

RENRAY HEALTHCARE LIMITED

STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

Page

Company Information

1

Strategic Report

2

Report of the Directors

3

Report of the Independent Auditors

5

Income Statement

9

Other Comprehensive Income

10

Balance Sheet

11

Statement of Changes in Equity

13

Notes to the Financial Statements

14

DIRECTORS:

G D Silman

J A Dearden

SECRETARY:

K Fairhurst

REGISTERED OFFICE:

Road 5

Winsford Industrial Estate

Winsford

Cheshire

CW7 3RB

REGISTERED NUMBER:

06434893 (England and Wales)

AUDITORS:

Clarke Nicklin LLP

Chartered Accountants and

Statutory Auditors

Clarke Nicklin House

Brooks Drive

Cheadle Royal Business Park

Cheadle

Cheshire

SK8 3TD

The directors present their strategic report for the year ended 31 December 2024.

REVIEW OF BUSINESS

Since the start of 2024 the healthcare market has been regarded as a soft market. Demand from customers has been decreasing in general.

Turnover fell by 3.7% in 2024 and the Directors consider this to be acceptable in this soft marketplace.

The Company suffered a loss in gross margin (29.8% 2024; 32.3% 2023). Higher direct labour costs contributed to this reduction as manufacturing in the UK continues to be difficult.

As reported in the 2023 accounts, the senior management team was strengthened on 2024 and this was a factor in the 6.2% increase in overhead.

The Company suffered an operating loss of £459k (operating profit £524k 2023) which the Directors consider as very disappointing. Cost-saving measures were started towards the end of 2024 and the target is to move back to profitability in 2025.

A vertical F&K Foam CNC machine was bought in 2024 to compliment the horizontal CNC machine operated by our group company. This enables all foam conversion to be done in house.

The business is now in a better position to control fluctuating foam costs and to be able to target the foam and hybrid mattress market. The Directors are now particularly pleased to be offering class 2a certified powered mattress range to its customer base.

PRINCIPAL RISKS AND UNCERTAINTIES

The soft market has continued into 2025 with many care home new builds now being in the 2nd half of the year. The Company's current order book is healthy and the Directors expect a strong trading performance before the end of the year.

Working capital management is a key area and more so as the Company gears up for growth. The Company has an invoice discounting facility and a trade finance facility in place to draw down on as required.

Retaining and developing key staff members is considered important by the Directors. The Company benefits from a very low level of staff turnover and the Directors do not consider staff retention as a concern.

ON BEHALF OF THE BOARD:

G D Silman - Director

18 September 2025

The directors present their report with the financial statements of the company for the year ended 31 December 2024.

PRINCIPAL ACTIVITY

The principal activity of the company in the year under review was that of the design, manufacture and distribution of furniture, furnishings and soft furnishings to the healthcare market.

DIVIDENDS

The total distribution of dividends for the year ended 31 December 2024 was £503,970 (2023: £474,124). The directors recommend that no final dividends be paid.

DIRECTORS

The directors shown below have held office during the whole of the period from 1 January 2024 to the date of this report.

G D Silman

J A Dearden

STATEMENT OF DIRECTORS' RESPONSIBILITIES

The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-	select suitable accounting policies and then apply them consistently;

-	make judgements and accounting estimates that are reasonable and prudent;

-	prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS

So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS

The auditors, Clarke Nicklin LLP, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:

G D Silman - Director

18 September 2025

Opinion

We have audited the financial statements of Renray Healthcare Limited (the 'company') for the year ended 31 December 2024 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

-	give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its loss for the year then ended;

-	have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

-	have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

-	the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and

-	the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

-	adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

-	the financial statements are not in agreement with the accounting records and returns; or

-	certain disclosures of directors' remuneration specified by law are not made; or

-	we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Procedures to identify risks:

-

enquiring of management concerning the company's procedures relating to: identifying, evaluating and complying with laws and regulations and whether they were aware of any instances of noncompliance; detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected or alleged fraud;

-

discussing among the engagement team regarding how and where fraud might occur in the financial statements and any potential indicators of fraud. As part of this discussion, we identified potential for fraud in the following areas: timing of recognition of sales and purchases and their related stock movements, posting of unusual journals; and

-

obtaining an understanding of the legal and regulatory frameworks that the company operates in, focusing on those laws and regulations that had a direct effect on the financial statements or that had a fundamental effect on the operations of the company. The key laws and regulations we considered in this context included UK Companies Act, employment law, health and safety, pensions legislation and tax legislation.

The procedures to respond to risks identified included:

-

reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with relevant laws and regulations discussed above;

-

enquiring of management, concerning actual and potential litigation and claims;

-

performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud;

-

reviewing correspondence with HMRC;

-

testing the timing and matching of income and expense transactions relating to stock movements either side of the year end; and

-

in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.

We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

There are inherent limitations in the audit procedures described above. We are less likely to become aware of instances of non-compliance with laws and regulation that are not closely related to events and transactions reflected in the financial statements. The risk of not detecting a material misstatement due to fraud is higher than the risk of not detection one resulting from an error, as fraud may involve deliberate concealment, by for example, forgery or intentional misrepresentation, or through collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Graham Travis FCA (Senior Statutory Auditor)

for and on behalf of Clarke Nicklin LLP

Chartered Accountants and

Statutory Auditors

Clarke Nicklin House

Brooks Drive

Cheadle Royal Business Park

Cheadle

Cheshire

SK8 3TD

18 September 2025

TURNOVER

17,321,621

18,002,671

Cost of sales

12,151,570

12,179,296

GROSS PROFIT

5,170,051

5,823,375

Administrative expenses

5,629,368

5,299,279

OPERATING (LOSS)/PROFIT

4

(459,317

)

524,096

Interest payable and similar expenses

5

126,782

81,418

(LOSS)/PROFIT BEFORE TAXATION

(586,099

)

442,678

Tax on (loss)/profit

6

(138,284

)

112,334

(LOSS)/PROFIT FOR THE FINANCIAL YEAR

(447,815

)

330,344

(LOSS)/PROFIT FOR THE YEAR

(447,815

)

330,344

OTHER COMPREHENSIVE INCOME

-

-

TOTAL COMPREHENSIVE INCOME FOR THE YEAR

(447,815

)

330,344

FIXED ASSETS

Tangible assets

8

781,330

681,820

CURRENT ASSETS

Stocks

9

2,337,060

2,217,968

Debtors

10

3,799,125

3,885,171

Investments

11

1,362

1,117

Cash at bank

467,448

740,755

6,604,995

6,845,011

CREDITORS

Amounts falling due within one year

12

3,473,144

2,518,254

NET CURRENT ASSETS

3,131,851

4,326,757

TOTAL ASSETS LESS CURRENT LIABILITIES

3,913,181

5,008,577

CREDITORS

Amounts falling due after more than one year

13

(603,465

)

(670,870

)

PROVISIONS FOR LIABILITIES

17

(43,191

)

(119,397

)

NET ASSETS

3,266,525

4,218,310

CAPITAL AND RESERVES

Called up share capital

18

3

3

Share premium

19

3,282,045

3,282,045

Retained earnings

19

(15,523

)

936,262

SHAREHOLDERS' FUNDS

3,266,525

4,218,310

The financial statements were approved by the Board of Directors and authorised for issue on 18 September 2025 and were signed on its behalf by:

G D Silman - Director

Called up

share

Retained

Share

Total

capital

earnings

premium

equity

£

£

£

£

Balance at 1 January 2023

3

1,080,042

3,282,045

4,362,090

Changes in equity

Dividends

-

(474,124

)

-

(474,124

)

Total comprehensive income

-

330,344

-

330,344

Balance at 31 December 2023

3

936,262

3,282,045

4,218,310

Changes in equity

Dividends

-

(503,970

)

-

(503,970

)

Total comprehensive income

-

(447,815

)

-

(447,815

)

Balance at 31 December 2024

3

(15,523

)

3,282,045

3,266,525

1.	COMPANY INFORMATION

Renray Healthcare Limited ("the Company") is a limited company incorporated in the United Kingdom. The address of its registered office and principal place of business is Road 5, Winsford Industrial Estate, Winsford, Cheshire, CW7 3RB.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with FRS 102 "The Financial Reporting Standard Applicable in the UK and Republic of Ireland" ("FRS 102") and applicable legislation as set out in the Companies Act 2006 and Schedule 1 of the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008. These financial statements have been prepared under the historical costs convention.

The financial statements are presented in Sterling (£).

Going concern

The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The directors have reached this conclusion giving due consideration to the projected future performance of the company and any potential risk that might impact the company's ability to meet its required solvency levels. For this reason, they continue to adopt the going concern basis in preparing the financial statements.

Financial Reporting Standard 102 - reduced disclosure exemptions

The company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":

•

the requirements of Section 7 Statement of Cash Flows;

•

the requirement of paragraph 33.7.

Significant judgements and estimates

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if revision only affects that period, or in the period of the revision and future periods if the revision affects both current and future periods.

The following judgements have had the most significant effect on amounts recognised in the financial statements;

Depreciation - The useful life of fixed assets can vary significantly. Estimates are based on historic experience and current expectations of useful life. The size of prior year gains and losses on disposal are also factored in to estimates.

Stock provision - The net realisable value of stock is assessed by the directors regularly. A provision is made where this falls below the cost. The provision is based on an ageing formula that has been reviewed and updated based on historic outcomes and current marketability of products.

Bad debts - The directors regularly review debts and provide for those which are doubtful.

Turnover

Turnover represents net invoiced sales of goods, excluding value added tax. Sales are recognised on the date of despatch to the customer.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Improvements to property

-

Straight line over 5 - 15 years

Plant and machinery

-

10% - 33% on cost

Fixtures and fittings

-

20% on cost

Motor vehicles

-

25% on cost

Computer equipment

-

33% on cost

Stocks

Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Current asset investments

Current asset investments are shown at market value.

Invoice discounting

The company uses an invoice discounting facility and has adopted separate presentation whereby gross debts are included as an asset and the amount due to the finance company is included within other creditors. The interest and charges are recognised as they accrue and are included in the profit and loss account.

Financial assets

Basic financial assets, including trade debtors, cash and bank balances and amounts owed by group undertakings, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest method.

At the end of each reporting period, financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in the income statement.

If there is a decrease in the the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been had the impairment not previously been recognised. The impairment reversal is recognised in the income statement.

Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party, or (c) control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.

Financial Liabilities

Basic financial liabilities, including trade creditors and amounts owed to group undertakings, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

3.	EMPLOYEES AND DIRECTORS

2024

2023

£

£

Wages and salaries

3,912,117

3,602,669

Social security costs

360,595

316,127

Other pension costs

45,636

38,522

4,318,348

3,957,318

The average number of employees during the year was as follows:

2024

2023

Administration and management

35

35

Distribution

8

8

Warehousing and production

42

42

85

85

2024

2023

£

£

Directors' remuneration

47,001

-

Directors' pension contributions to money purchase schemes

440

-

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes

2

-

4.	OPERATING (LOSS)/PROFIT

The operating loss (2023 - operating profit) is stated after charging/(crediting):

2024

2023

£

£

Depreciation - owned assets

99,858

114,889

Depreciation - assets on hire purchase contracts

98,587

64,593

Profit on disposal of fixed assets

(2,882

)

(15,000

)

Auditors' remuneration

26,205

25,060

Exchange rate (gains)/losses

12,033

2,486

Impairment of stock

(180,584

)

(185,797

)

5.

INTEREST PAYABLE AND SIMILAR EXPENSES

2024

2023

£

£

Bank interest

42,707

53,131

Factoring charges

56,641

9,372

Hire purchase interest

27,434

18,915

126,782

81,418

6.

TAXATION

Analysis of the tax (credit)/charge

The tax (credit)/charge on the loss for the year was as follows:

2024

2023

£

£

Current tax:

UK corporation tax

(64,340

)

62,078

Under provision in prior year

2,262

4,186

Total current tax

(62,078

)

66,264

Deferred tax

(76,206

)

46,070

Tax on (loss)/profit

(138,284

)

112,334

Reconciliation of total tax (credit)/charge included in profit and loss

The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2024

2023

£

£

(Loss)/profit before tax

(586,099

)

442,678

(Loss)/profit multiplied by the standard rate of corporation tax in the UK of 25% (2023 - 23.521%)

(146,525

)

104,122

Effects of:

Expenses not deductible for tax purposes

154

6,914

Income not taxable for tax purposes

-

(1,777

)

Depreciation in excess of capital allowances

1,778

4,530

Adjustments to tax charge in respect of previous periods

2,262

(1,455

)

Rate change on losses carried back

4,047

-

Total tax (credit)/charge

(138,284

)

112,334

7.

DIVIDENDS

2024

2023

£

£

Ordinary shares of £1 each

Interim

503,970

474,124

8.	TANGIBLE FIXED ASSETS

Improvements

Fixtures

to

Plant and

and

property

machinery

fittings

£

£

£

COST

At 1 January 2024

303,257

933,501

55,275

Additions

7,267

278,578

478

Disposals

-

-

(8,070

)

At 31 December 2024

310,524

1,212,079

47,683

DEPRECIATION

At 1 January 2024

248,598

651,424

51,628

Charge for year

14,382

66,546

886

Eliminated on disposal

-

-

(7,831

)

At 31 December 2024

262,980

717,970

44,683

NET BOOK VALUE

At 31 December 2024

47,544

494,109

3,000

At 31 December 2023

54,659

282,077

3,647

Motor

Computer

vehicles

equipment

Totals

£

£

£

COST

At 1 January 2024

1,062,986

203,115

2,558,134

Additions

47,700

4,695

338,718

Disposals

(116,259

)

(21,221

)

(145,550

)

At 31 December 2024

994,427

186,589

2,751,302

DEPRECIATION

At 1 January 2024

753,172

171,492

1,876,314

Charge for year

100,144

16,487

198,445

Eliminated on disposal

(75,735

)

(21,221

)

(104,787

)

At 31 December 2024

777,581

166,758

1,969,972

NET BOOK VALUE

At 31 December 2024

216,846

19,831

781,330

At 31 December 2023

309,814

31,623

681,820